1: Development and Implementation
2: Working Definition
3: Prevention
4: Evaluation of Ventricular Dysfunction
5: Asymptomatic Patients
6: Nonpharmacologic Management
7: Reduced Ejection Fraction
8: Disease Management, Advance Directives, End-of-Life Care
9: EP Testing and Use of Devices
10: Surgical Approaches
11: Preserved LVEF
12: Acute Decompensated HF
13: Ischemic Heart Disease
14: Hypertension and HF
15: HF in Special Populations
16: Myocarditis
17: Genetic Evaluation

About the Comprehensive Heart Failure Practice Guideline

This document was approved by the Heart Failure Society of America Executive Council in June 2010.

The document should be cited as follows: Lindenfeld J, Albert NM, Boehmer JP, Collins SP, Ezekowitz JA, Givertz MM, Klapholz M, Moser DK, Rogers JG, Starling RC, Stevenson WG, Tang WHW, Teerlink JR, Walsh MN. Executive Summary: HFSA 2010 Comprehensive Heart Failure Practice Guideline. J Card Fail 2010;16:475-539.

A copy of this document is available on the HFSA web site (www.hfsa.org). To obtain a reprint of the Executive Summary published in the July 2010 issue of Journal of Cardiac Failure please call 651.642.1633, fax 651.642.1502, or e-mail info@hfsa.org.

Multiple copies, modification, alteration, enhancement, and/or distribution of this document are not permitted with the express written permission of the Heart Failure Society of America. Please direct requests to info@hfsa.org.

©2010 HFSA
Disclaimer
Privacy Policy
Site Map

Twitter